Matches in Wikidata for { <http://www.wikidata.org/entity/Q91392595> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q91392595 description "2018 թվականի սեպտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q91392595 description "article scientifique publié en 2018" @default.
- Q91392595 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91392595 description "scientific article published on 11 September 2018" @default.
- Q91392595 description "wetenschappelijk artikel" @default.
- Q91392595 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91392595 name "Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers" @default.
- Q91392595 name "Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers" @default.
- Q91392595 type Item @default.
- Q91392595 label "Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers" @default.
- Q91392595 label "Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers" @default.
- Q91392595 prefLabel "Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers" @default.
- Q91392595 prefLabel "Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers" @default.
- Q91392595 P1433 Q91392595-AF59D79D-29C1-4BEC-A22A-5616B9944734 @default.
- Q91392595 P1476 Q91392595-26E5F394-5CD0-41FD-B9CB-F3169D295555 @default.
- Q91392595 P2093 Q91392595-002B902B-1043-4B53-A63B-9E029CA721C7 @default.
- Q91392595 P2093 Q91392595-588F89B6-4436-4A65-917B-D1CE2D91E0BE @default.
- Q91392595 P2093 Q91392595-7A842B56-59FE-42A7-8FC0-623350DA4616 @default.
- Q91392595 P2093 Q91392595-7D11912F-3ABF-4B53-832F-65C5E2EC4EA5 @default.
- Q91392595 P2093 Q91392595-8B0ED325-EAAC-41D3-BBF3-C502FD37A2B5 @default.
- Q91392595 P2093 Q91392595-8F5F5F6E-EEA7-44BB-A67A-0EA391088279 @default.
- Q91392595 P2093 Q91392595-9CB71006-6AA0-4D80-8CC7-758E7D8011FD @default.
- Q91392595 P2093 Q91392595-A76306CB-CA48-4312-9532-0C5931E5FC2B @default.
- Q91392595 P2093 Q91392595-B47D2BF8-4D94-48A2-98AF-3ABE26CB3D9A @default.
- Q91392595 P2093 Q91392595-BA7D5E48-E983-402F-99A6-CBE7F8270279 @default.
- Q91392595 P2093 Q91392595-C4CAFA6E-0629-450F-9A0D-C7F043357721 @default.
- Q91392595 P2093 Q91392595-C8C0605B-C7BD-401E-86F1-67CF11FC2648 @default.
- Q91392595 P2093 Q91392595-C8F5CF94-DC9D-4775-A50A-E88F29FCBEDA @default.
- Q91392595 P2093 Q91392595-E451BA45-C3AF-405B-A633-FE147C8A5656 @default.
- Q91392595 P2093 Q91392595-FC80B67A-A5DB-4EC8-9BC1-20031F1B6244 @default.
- Q91392595 P2860 Q91392595-0F4597DF-4BAE-4DC0-8255-7699F082EBA6 @default.
- Q91392595 P304 Q91392595-1F3B41F5-285D-4F5C-900E-0B12DE19779D @default.
- Q91392595 P31 Q91392595-47E371D9-2B84-4A61-9486-E2714778BA2B @default.
- Q91392595 P356 Q91392595-5D106424-75E8-4D7E-81F5-BF48AEB8D1F3 @default.
- Q91392595 P433 Q91392595-67BAC1F6-9BE1-43DB-A295-6FBD5CF3AFCE @default.
- Q91392595 P478 Q91392595-E3A031A3-5876-4844-9EA8-4D5030BF36F6 @default.
- Q91392595 P50 Q91392595-5152A051-E4A9-4A8B-A0BF-575522C97B9F @default.
- Q91392595 P50 Q91392595-C12C96A3-0294-409C-B0AA-443573F642D5 @default.
- Q91392595 P577 Q91392595-F10543DF-4604-4892-8B04-0CAEC13CF607 @default.
- Q91392595 P698 Q91392595-670CF2D0-01EA-499A-B613-46C9588C4A80 @default.
- Q91392595 P921 Q91392595-4EB35FEB-5548-4E46-B515-CA35A3722325 @default.
- Q91392595 P921 Q91392595-76B85A4A-AA7D-4A55-A759-0C3918A01A18 @default.
- Q91392595 P356 1078-0432.CCR-18-1590 @default.
- Q91392595 P698 30206164 @default.
- Q91392595 P1433 Q332253 @default.
- Q91392595 P1476 "Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers" @default.
- Q91392595 P2093 "Achim Rittmeyer" @default.
- Q91392595 P2093 "Augusto Villegas" @default.
- Q91392595 P2093 "Christina S Baik" @default.
- Q91392595 P2093 "Christoph Meyenberg" @default.
- Q91392595 P2093 "Dariusz M Kowalski" @default.
- Q91392595 P2093 "Dolores Isla" @default.
- Q91392595 P2093 "Javier De Castro Carpeno" @default.
- Q91392595 P2093 "Lukas Bubendorf" @default.
- Q91392595 P2093 "Marcello Tiseo" @default.
- Q91392595 P2093 "Michael W Lu" @default.
- Q91392595 P2093 "Philip Bonomi" @default.
- Q91392595 P2093 "Rolf Stahel" @default.
- Q91392595 P2093 "Sanne de Haas" @default.
- Q91392595 P2093 "Solange Peters" @default.
- Q91392595 P2093 "Thomas E Stinchcombe" @default.
- Q91392595 P2860 Q34880994 @default.
- Q91392595 P304 "64-72" @default.
- Q91392595 P31 Q13442814 @default.
- Q91392595 P356 "10.1158/1078-0432.CCR-18-1590" @default.
- Q91392595 P433 "1" @default.
- Q91392595 P478 "25" @default.
- Q91392595 P50 Q56885798 @default.
- Q91392595 P50 Q91392591 @default.
- Q91392595 P577 "2018-09-11T00:00:00Z" @default.
- Q91392595 P698 "30206164" @default.
- Q91392595 P921 Q412616 @default.
- Q91392595 P921 Q864574 @default.